A5000370948- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Heme Oxygenase-1 and Carbon Monoxide
- Inflammatory Biomarkers in Disease Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Yersinia bacterium, plague, ectoparasites research
- Chemokine receptors and signaling
- Microbial infections and disease research
- Respiratory viral infections research
- Ovarian cancer diagnosis and treatment
- Hepatitis B Virus Studies
- Cancer Immunotherapy and Biomarkers
- Pneumonia and Respiratory Infections
- Legionella and Acanthamoeba research
Sun Yat-sen University
2022-2025
The First Affiliated Hospital, Sun Yat-sen University
2022-2025
Transarterial chemoembolization (TACE) is a potential conversion therapeutic strategy for unresectable hepatocellular carcinoma (uHCC). However, options following therapy are still controversial. This study aimed to compare the efficacy and safety of surgical resection (SR) microwave ablation (MWA) after TACE uHCC. A retrospective, multi-institutional study. From June 2008 October 2022, 8842 consecutive uHCC patients underwent initial at 15 hospitals were identified. Among them, 1348...
Abstract Aim This study aims to investigate α‐fetoprotein (AFP) trajectories for prediction of survival outcomes after hepatic arterial infusion chemotherapy (HAIC) treatment in large hepatocellular carcinoma (HCC). Methods From May 2014 June 2020, 889 eligible patients with HCC underwent HAIC were retrospectively enrolled from five hospitals. A latent class growth mixed (LCGM) model was applied distinguish potential AFP level dynamic changing trajectories. Inverse‐probability‐of‐treatment...
To examine the clinical significance of circulating lymphocyte subtypes and cytokines in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE).We enrolled 53 assessed subsets (CD4+ T cells, CD8+ CD4+/CD8+ cell ratio, natural killer regulatory cells) (interleukin [IL]-2, IL-4, IL-6, IL-10, interferon [IFN]-γ) on day before TACE, 1 4-8 weeks thereafter. The correlation between baseline inflammatory markers differences subgroups, prognostic values...